We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lung Cancer, Iron Deficiency Candidates Move Forward in Europe
Lung Cancer, Iron Deficiency Candidates Move Forward in Europe
A number of drugmakers got good news from the European Medicines Agency’s Committee for Medicinal Products for Human Use, including two companies looking to have their lung cancer candidates approved in Europe.